Metabolic Dysfunction-Associated Steatohepatitis (MASH) Research Samples
37 Results
1 - 37 of 37 total samples.
Advanced Data View:
1 - 37 of 37 total samples.
Buy | Product ID | Sample | Origin | Matrix | Vial (ml) | Quantity | Price | Age | Gender | Ethnicity | Storage Temp | Sample Date | Test 1 | Test 1 Result | Test 1 Detail | Test 2 | Test 2 Result | Test 3 | Test 3 Result | Product Details | Price | Buy | Elastography Result | Comorbidities | Smoking Status | Alcohol Consumption | HIV-I/II, Hepatitis B, Hepatitis C Test Results | Ultrasound Result | Diagnosis | HIV-I/II result | Hepatitis B result | Hepatitis C result | CT / MRI results |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BF19871141 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 44 Y | M | White | <-70C | 08-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 8-Aug-2025 | Height | 190 cm | Weight | 130 kg | $400.00 | Liver stiffness, as measured by elastography, is consistent with METAVIR F1 stage fibrosis 8-Aug-2025 | Obesity class II 2011 | Previous Cigarette Use (15/day, 5 years, Quit in 2011) | Previous Use (2/day, 5 years, Quit in 2011) | Negative | |||||||||
| BF19871143 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 55 Y | M | White | <-70C | 08-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 2024 | Height | 170 cm | Weight | 127 kg | $400.00 | Liver stiffness, as measured by elastography, is consistent with METAVIR F2 stage fibrosis 6-Oct-2025 | Obesity class III; Diabetes mellitus type 2 2010; 2020 | Never used | Never used | Negative | |||||||||
| BF19871146 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 44 Y | M | White | <-70C | 07-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 7-Oct-2025 | Height | 170 cm | Weight | 130 kg | $400.00 | Sonographic signs of chronic hepatitis, consistent with METAVIR F2 fibrosis, and severe hepatic steatosis 7-Oct-2025 | Obesity class III; Hypertension 2019; 2020 | Never used | Never used | Negative | |||||||||
| BF19871150 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 54 Y | M | White | <-70C | 09-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 9-Oct-2025 | Height | 164 cm | Weight | 68 kg | $400.00 | Sonographic signs of chronic hepatitis, consistent with METAVIR F3 fibrosis, and severe hepatic steatosis 9-Oct-2025 | Chronic obstructive pulmonary disease; Hypertension; Ischemic heart disease 2018; 2020; 2020 | Current Cigarette Use (25/day, 18 years) | Never used | Negative | |||||||||
| BF19871151 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 53 Y | M | White | <-70C | 16-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 2021 | Height | 176 cm | Weight | 86 kg | $400.00 | Mean liver stiffness: 6.56 kPa (F1-2 by METAVIR) 16-Oct-2025 | Hypertension; Ischemic heart disease 2020; 2022 | Never used | Never used | Negative | |||||||||
| BF19871153 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 13.00 | $400.00 | 68 Y | M | White | <-70C | 10-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 10-Oct-2025 | Height | 180 cm | Weight | 110 kg | $400.00 | Ultrasound signs of diffuse liver changes, consistent with METAVIR F1 fibrosis, and moderate hepatic steatosis 10-Oct-2025 | Hypertension; Ischemic heart disease; Diabetes mellitus type 2 2013; 2016; 2019 | Never used | Never used | Negative | |||||||||
| BF19871168 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 14.00 | $400.00 | 43 Y | M | White | <-70C | 01-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 1-Oct-2025 | Height | 182 cm | Weight | 90 kg | $400.00 | Mean liver stiffness: 6.8 kPa (F1 by METAVIR) 1-Oct-2025 | N/A | Current Cigarette Use (15/day, 20 years) | Never used | Negative | Hepatosplenomegaly. Moderate gallbladder sludge, diffuse pancreatic changes | ||||||||
| BF19871171 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 30 Y | M | White | <-70C | 06-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 6-Oct-2025 | Height | 172 cm | Weight | 89 kg | $400.00 | Mean liver stiffness: 7.2 kPa (F1-F2 by METAVIR) 6-Oct-2025 | N/A | Current Cigarette Use (15/day, 10 years) | Never used | Negative | Signs of hepatosplenomegaly, cholesterolosis of the gallbladder, diffuse changes of the pancreas, focally altered areas in the spleen structure | ||||||||
| BF19871173 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 50 Y | M | White | <-70C | 02-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 2-Oct-2025 | Height | 175 cm | Weight | 84 kg | $400.00 | Mean liver stiffness: 7.0 kPa (F1 by METAVIR) 2-Oct-2025 | N/A | Current Cigarette Use (15/day, 27 years) | Never used | Negative | Signs of hepatic steatosis and biliary sludge | ||||||||
| BF19871191 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 46 Y | M | White | <-70C | 21-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 2022 | Height | 172 cm | Weight | 69 kg | $400.00 | Mean liver stiffness: 7.8 kPa (F2 by METAVIR) 20-Oct-2025 | Hypertension 2023 | Current Cigarette Use (15/day, 10 years) | Never used | Negative | |||||||||
| BF19871232 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 1.00 | $500.00 | 58 Y | M | White | <-70C | 14-Feb-25 | BMI | 25.73 | Height | 173 cm | Weight | 77 kg. | $500.00 | Oblique vertical size of the right lobe 171 mm, left lobe 80 mm. The structure is changed. K3 is 268 dB/m. Steatosis S2. Fatty degeneration is 51%. 3-Feb-25 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) 2017 | Negative | Negative | Negative | N/A | |||||||||
| BF19871235 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 1.00 | $500.00 | 43 Y | M | White | <-70C | 17-Feb-25 | BMI | 25.5 | Height | 176 cm | Weight | 79 kg. | $500.00 | Shape, structure of the liver is changed due to fatty degeneration. 60% fatty hepatosis. Steatosis S2. K3 is 280 dB/m 31-Jan-25 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) 2018 | Negative | Negative | Negative | N/A | |||||||||
| BF19871241 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 1.00 | $500.00 | 55 Y | M | White | <-70C | 12-Feb-25 | BMI | 28.39 | Height | 172 cm | Weight | 84 kg. | $500.00 | Oblique vertical size of the right lobe is 172 mm, the left lobe is 74 mm. The structure is changed, fatty degeneration is 50%. K3 is 265 dB/m. Steatosis S2. 23-Jan-25 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) 2012 | Negative | Negative | Negative | N/A | |||||||||
| BF19871263 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 1.00 | $500.00 | 61 Y | M | White | <-70C | 27-Feb-25 | BMI | 35.43 | Height | 168 cm | Weight | 100 kg. | $500.00 | The average value of the elasticity of the parenchyma of the liver is 6.2 kPa. On the METAVIR scale - F1. Severe steatosis. 26-Feb-25 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) 26-Feb-25 | Negative | Negative | Negative | The liver is enlarged, the contours are even and clear. The structure of the parenchyma is heterogeneous. | |||||||||
| BF19871264 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 1.00 | $500.00 | 38 Y | M | White | <-70C | 14-Feb-25 | BMI | 24.07 | Height | 180 cm | Weight | 78 kg. | $500.00 | Oblique vertical size of the right lobe is 175 mm, the left lobe is 76 mm. The structure is slightly changed, fatty degeneration is 48%. K3 is 262 dB/m. Steatosis S2. 24-Jan-25 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) 2020 | Negative | Negative | Negative | N/A | |||||||||
| BF19871265 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 1.00 | $500.00 | 58 Y | F | White | <-70C | 18-Feb-25 | BMI | 26.45 | Height | 165 cm | Weight | 72 kg. | $500.00 | The average value of the elasticity of the parenchyma of the liver is 5.5 kPa. On the METAVIR scale - F0. 18-Feb-25 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) 2024 | Negative | Negative | Negative | N/A | |||||||||
| BF19871269 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 1.00 | $500.00 | 54 Y | M | White | <-70C | 12-Feb-25 | BMI | 24.11 | Height | 174 cm | Weight | 73 kg. | $500.00 | Oblique vertical size of the right lobe is 177 mm, the left lobe is 77 mm. The structure is changed, fatty degeneration is 71%. K3 is 293 dB/m. Steatosis S3. 21-Jan-25 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) 2018 | Negative | Negative | Negative | N/A | |||||||||
| BF19871278 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 1.00 | $500.00 | 34 Y | M | White | <-70C | 14-Feb-25 | BMI | 29.41 | Height | 172 cm | Weight | 87 kg. | $500.00 | The average value of the elasticity of the parenchyma of the liver is 4.5 kPa. On the METAVIR scale - F0. 14-Feb-25 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) 2023 | Negative | Negative | Negative | N/A | |||||||||
| BF19871285 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 1.00 | $500.00 | 47 Y | M | White | <-70C | 14-Feb-25 | BMI | 25.43 | Height | 174 cm | Weight | 77 kg. | $500.00 | Oblique vertical size of the right lobe 169 mm, left lobe 70 mm. The structure is changed, fatty degeneration 68%. K3 is 292 dB/m. Steatosis S3. 30-Jan-25 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) 2020 | Negative | Negative | Negative | N/A | |||||||||
| BF19871331 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 45 Y | M | White | <-70C | 27-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 2020 | Height | 184 cm | Weight | 120 kg | $400.00 | Mean liver stiffness: 6.95 kPa (F1-F2 by METAVIR) 15-Oct-2025 | Diabetes mellitus type 2; Obesity class II 2008; 2004 | Never used | Never used | Negative | |||||||||
| BF19871333 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 46 Y | M | White | <-70C | 27-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 2022 | Height | 183 cm | Weight | 117 kg | $400.00 | Mean liver stiffness: 6.73 kPa (F1-F2 by METAVIR) 1-Oct-2025 | Obesity class I 2020 | Never used | Previous Use (1/day, 13 years, Quit in 2020) | Negative | |||||||||
| BF19871343 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 35 Y | M | White | <-70C | 14-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 2020 | Height | 187 cm | Weight | 127 kg | $400.00 | Mean liver stiffness: 7.34 kPa (F1-F2 by METAVIR) 5-Oct-2025 | Diabetes mellitus type 2; Obesity class II 2010; 2018 | Never used | Never used | Negative | |||||||||
| BF19871344 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 53 Y | M | White | <-70C | 27-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 2018 | Height | 190 cm | Weight | 110 kg | $400.00 | Mean liver stiffness: 7.0 kPa (F1-F2 by METAVIR) 1-Oct-2025 | Diabetes mellitus type 2; Obesity class I 2008; 2005 | Never used | Never used | Negative | |||||||||
| BF19871346 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 51 Y | F | White | <-70C | 14-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 2024 | Height | 168 cm | Weight | 99 kg | $400.00 | Mean liver stiffness: 6.94 kPa (F1-F2 by METAVIR) 29-Sep-2025 | Obesity class II 2010 | Never used | Previous Use (2/day, 8 years, Quit in 2015) | Negative | |||||||||
| BF19871351 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 14.00 | $400.00 | 43 Y | M | White | <-70C | 20-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 20-Oct-2025 | Height | 170 cm | Weight | 86 kg | $400.00 | Mean liver stiffness: 7.5 kPa (F2 by METAVIR) 20-Oct-2025 | N/A | Current Cigarette Use (15/day, 10 years) | Never used | Negative | |||||||||
| BF19871352 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 45 Y | M | White | <-70C | 14-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 14-Oct-2025 | Height | 169 cm | Weight | 87 kg | $400.00 | Mean liver stiffness: 7.8 kPa (F2 by METAVIR) 14-Oct-2025 | Obesity class I 2015 | Current Cigarette Use (15/day, 20 years) | Never used | Negative | |||||||||
| BF19871354 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 42 Y | M | White | <-70C | 20-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 20-Oct-2025 | Height | 171 cm | Weight | 89 kg | $400.00 | Mean liver stiffness: 7.2 kPa (F1-F2 by METAVIR) 20-Oct-2025 | Obesity class I 2018 | Current Cigarette Use (15/day, 13 years) | Never used | Negative | |||||||||
| BF19871355 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 63 Y | M | White | <-70C | 15-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 15-Oct-2025 | Height | 176 cm | Weight | 82 kg | $400.00 | Mean liver stiffness: 6.8 kPa (F1 by METAVIR) 15-Oct-2025 | Heart failure 2016 | Current Cigarette Use (15/day, 35 years) | Never used | Negative | |||||||||
| BF19871364 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 12.00 | $400.00 | 50 Y | F | White | <-70C | 04-Nov-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 4-Nov-2025 | Height | 168 cm | Weight | 99 kg | $400.00 | Mean liver stiffness: 6.2 kPa (F1 by METAVIR) 4-Nov-2025 | Hypertension; Obesity class II; Chronic obstructive pulmonary disease 2016; 2015; 2010 | Never used | Never used | Negative | |||||||||
| BF19871367 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 14.00 | $400.00 | 60 Y | M | White | <-70C | 06-Nov-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 2021 | Height | 172 cm | Weight | 88 kg | $400.00 | Mean liver stiffness: 6.3 kPa (F1 by METAVIR) 6-Nov-2025 | Dilated cardiomyopathy. Heart failure; Chronic pancreatitis 2019; 2020 | Never used | Never used | Negative | |||||||||
| BF19871369 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 14.00 | $400.00 | 64 Y | M | White | <-70C | 05-Nov-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 2008 | Height | 172 cm | Weight | 82 kg | $400.00 | Mean liver stiffness: 7.42 kPa (F2 by METAVIR) 5-Nov-2025 | Hypertension; Diabetes mellitus type 2 2010; 2015 | Never used | Never used | Negative | |||||||||
| BF19871374 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 55 Y | M | White | <-70C | 03-Nov-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 2023 | Height | 173 cm | Weight | 100 kg | $400.00 | Mean liver stiffness: 7.41 kPa (F1-F2 by METAVIR) 2-Sep-2025 | Obesity class I 2010 | Previous Cigarette Use (15/day, 15 years, Quit in 2008) | Previous Use (2/day, 15 years, Quit in 2010) | Negative | |||||||||
| BF19871375 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 58 Y | F | White | <-70C | 03-Nov-25 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 2020 | Height | 160 cm | Weight | 90 kg | $400.00 | Mean liver stiffness: 6.85 kPa (F1-F2 by METAVIR) 26-Sep-2025 | Diabetes mellitus type 2; Obesity class II 2010; 2016 | Never used | Never used | Negative | |||||||||
| BF19871445 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 35 Y | M | White | <-70C | 23-Jan-26 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 23-Jan-26 | Height | 182 cm | Weight | 89 kg | $400.00 | Mean liver stiffness: 6.8 kPa (F1 by METAVIR) 23-Jan-26 | N/A | Current Cigarette Use (15/day, 7 years) | Current Use (3/day, 7 years) | Negative | |||||||||
| BF19871450 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 74 Y | F | White | <-70C | 27-Jan-26 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 26-Jan-26 | Height | 160 cm | Weight | 59 kg | $400.00 | Mean liver stiffness: 6.3 kPa (F1 by METAVIR) 27-Jan-26 | N/A | Never used | Previous Use (2/day, 25 years, Quit in 2024) | Negative | |||||||||
| BF19871451 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 55 Y | M | White | <-70C | 16-Jan-26 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 16-Jan-26 | Height | 180 cm | Weight | 92 kg | $400.00 | Mean liver stiffness: 6.6 kPa (F1 by METAVIR) 16-Jan-26 | N/A | Current Cigarette Use (15/day, 10 years) | Current Use (3/day, 10 years) | Negative | |||||||||
| BF19871454 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 35 Y | M | White | <-70C | 22-Jan-26 | Diagnosis | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 22-Jan-26 | Height | 179 cm | Weight | 76 kg | $400.00 | Mean liver stiffness: 6.5 kPa (F1 by METAVIR) 22-Jan-26 | N/A | Never used | Never used | Negative |